Qasi Najah, Amro Mamdouh Abdelrehim, Mohamed Elmallahy, Ayah Alsubayhay, Yasmeen Jamal Alabdallat
PURPOSE: Extensive  intraperitoneal lavage (EIPL) is a novel therapeutic intervention that aims to limit the chance of peritoneal metastasis during gastrectomy. Clinical trials on using EIPL after gastrectomy show controversial results. We aimed to summarize the evidence of efficacy and safety for using EIPL after gastrectomy to limit the possibility of peritoneal metastasis and improve survival. METHODS: A literature search on PubMed, Scopus, Embase, and Web of Sciences was conducted till June 2023 to identify eligible RCTs that assess the efficacy and safety of EIPL after gastrectomy...
September 26, 2023: Journal of Gastrointestinal Cancer
Mustafa Korkmaz, Melek Karakurt Eryılmaz, Muhammed Muhiddin Er, Mehmet Zahid Koçak, Aykut Demirkıran, Mustafa Karaağaç, Murat Araz, Mehmet Artaç, Zahid Mehmet Koçak
PURPOSE: The prognostic nutritional index (PNI), like other systemic inflammatory markers, has been shown to be a prognostic factor in various cancer patients. In this study, we aimed to show whether PNI calculated before adjuvant chemotherapy is a prognostic factor for overall survival (OS) and disease-free survival (DFS) in patients with lymph node-positive stage II-III gastric cancer. METHODS: The PNI was calculated using the albumin and lymphocyte count. The PNI cut-off value was found to be 39...
September 22, 2023: Journal of Gastrointestinal Cancer
Cho-Han Chiang, Cho-Hung Chiang, Yuan Ping Hsia, Brian Shiian Chen, Aunchalee Jaroenlapnopparat, Cho-Hsien Chiang, Cheng-Ming Peng
BACKGROUND: Cationic amphiphilic H1-antihistamines have demonstrated antitumor effects in preclinical studies. We conducted a retrospective cohort study to investigate their impact on patients with pancreatic adenocarcinoma (PDAC). METHODS: We performed a matched cohort study involving PDAC patients from two tertiary centers in Taiwan using criteria including age, sex, and cancer stage. The primary outcome was overall survival (OS), and the secondary outcomes were progression-free survival (PFS) and objective response rates (ORR)...
September 14, 2023: Journal of Gastrointestinal Cancer
Yong-Eun Park, Hyundong Chae
PURPOSE: Due to significant growth in the volume of information produced by cancer research, staying abreast of recent developments has become a challenging task. Artificial intelligence (AI) can learn, reason, and understand the enormous corpus of literature available to the scientific community. However, large-scale studies comparing the recommendations of AI and a multidisciplinary team board (MTB) in gastric cancer treatment have rarely been performed. Therefore, a retrospective real-world study was conducted to assess the level of concordance between AI and MTB treatment recommendations...
September 13, 2023: Journal of Gastrointestinal Cancer
Adila Amariyil, Sushmita Pathy, Atul Sharma, Sunil Kumar, Raja Pramanik, Sandeep Bhoriwal, R M Pandey
BACKGROUND: Management of locally advanced rectal cancer (LARC) is evolving with current emphasis on the addition of chemotherapy to short course radiotherapy (SCRT). We primarily aimed to analyse the difference in overall response rates between SCRT with sequential chemotherapy and standard long-course chemoradiotherapy (LCCRT)in LARC. METHODS: After randomization, patients in arm A received 45 Gy in 25 fractions over 5 weeks with concurrent capecitabine while patients in arm B received 25 Gy in 5 fractions over 1 week followed by 3 cycles of CAPOX (capecitabine and oxaliplatin) chemotherapy...
September 13, 2023: Journal of Gastrointestinal Cancer
Christian Mouawad, Houssam Dahboul, Daniel Kazan, Bilal Chamaa, Michael Osseis, Roger Noun, Ghassan Chakhtoura
INTRODUCTION: One anastomosis gastric bypass (OAGB) is mainly criticized for the supposed carcinogenic effect of bile reflux on the gastric pouch mucosa. CASE PRESENTATION: A 56-year-old male patient presented 12 years after OAGB with a 10-month history of gradual dysphagia and vomiting. He was diagnosed with a tumor of the gastro-jejunal anastomosis, and underwent total gastrectomy with D2 lymphadenectomy. Specimen examination showed a diffuse isolated cell-type adenocarcinoma...
September 10, 2023: Journal of Gastrointestinal Cancer
Smriti Mishra, Gaurang Telang, Darpan Bennur, Shruti Chougule, P B Dandge, Shantanu Joshi, Nishant Vyas
BACKGROUND: T cell exhaustion and activation markers are helpful in determining the therapies and predicting the overall survival in pancreatic cancer (PC) patients. PURPOSE: In this systematic review, we have addressed two questions, how do these markers differ in their expression levels in PC patients and healthy individual and correlating the expression level of these markers with the cancer stage. METHODS: The systematic review was registered with Prospective Register of Systematic Reviews (PROSPERO) with registration number "CRD42022246780...
September 6, 2023: Journal of Gastrointestinal Cancer
Sarah Nash, Kristin Weeks, Amanda R Kahl, Natalie J Del Vecchio, Xiang Gao, Kristina Guyton, Mary Charlton
PURPOSE: Rectal cancer treatment at high-volume centers is associated with higher likelihood of guideline-concordant care and improved outcomes. Whether rectal cancer patients are referred for treatment at high-volume hospitals may depend on diagnosing provider specialty. We aimed to determine associations of diagnosing provider specialty with treating provider specialty and characteristics of the treating facility for rectal cancer patients in Iowa. METHODS: Rectal cancer patients identified using the Iowa Cancer Registry completed a mailed survey on their treatment experience and decision-making process...
August 30, 2023: Journal of Gastrointestinal Cancer
Florinda A Santos, Rui Manuel Reis, Lucas C Barroti, Allan A L Pereira, Marcus M Matsushita, Ana Carolina de Carvalho, José Guilherme Datorre, Gustavo N Berardinelli, Raphael L C Araujo
PURPOSE: Evaluate overall survival (OS), RAS, BRAF, and MSI frequencies in patients with metastatic colorectal cancer (mCRC), refractory to chemotherapy, and finally treated with cetuximab. METHODS: A retrospective cohort study to evaluate 211 mCRC patients with wild-type KRAS treated with cetuximab. BRAF V600E, KRAS, NRAS gene mutations, and MSI status were identified using PCR techniques in a population of pre-treated patients who were refractory to fluoropyrimidines, oxaliplatin, and irinotecan...
August 23, 2023: Journal of Gastrointestinal Cancer
Maedeh Amini, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Mohammad Reza Zali
BACKGROUND: Colorectal cancer (CRC) screening and detecting it at an early stage is an effective way to decrease mortality from CRC. Colonoscopy, considered the gold standard (GS) for diagnosing the disease in many countries, has several limitations. Therefore, the main focus of this literature is to investigate the ability of combining candidate gut microbiota for early diagnosis of CRC, both in the presence and absence of GS test outcomes. METHODS: We analyzed the data derived from a case-control study, including 83 screening colonoscopies conducted on subjects aged 18-92 years in Tehran, Iran...
August 11, 2023: Journal of Gastrointestinal Cancer
Mansour Bahardoust, Safa Mousavi, Zahra Deylami Moezi, Mohsen Yarali, Ali Tayebi, Faranak Olamaeian, Adnan Tizmaghz
BACKGROUND: Gastric cancer (GC) is one of the most common worldwide cancers and causes of death. Various studies have investigated the effect of metformin on overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and recurrence rate in diabetic patients after gastrectomy, and their results have been contradictory. This meta-analysis aimed to evaluate the effect of metformin use compared to sulfonylurea compounds with OS, CSS, RFS, and recurrence rate after gastrectomy in diabetic patients...
August 1, 2023: Journal of Gastrointestinal Cancer
Ishith Seth, Adrian Siu, Lyndel Hewitt, Ulvi Budak, Beshoy Farah, Mouhannad Jaber
BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, including Australia. The absence of a consensus clinical practice guideline (CPG) specific to HCC management poses challenges in reducing morbidity, mortality, and improving patient recovery. This systematic review aims to evaluate the existing evidence and assess the potential of published guidelines, including those with an international scope, to provide guidance for healthcare professionals in Australia...
July 22, 2023: Journal of Gastrointestinal Cancer
Ajoy Oommen John, Ashish Singh, Divya Bala, Anjana Joel, Josh Thomas Georgy, Mark Ranjan Jesudasan, Rohin Mittal, Thomas Samuel Ram, Jebakarunya Rami Reddy, Arvind Murthy, Anuradha Chandramohan, Anu Eapen, Dipti Masih, Nithya Ramnath, Irina Dobrosotskaya, Bijesh Yadav, Raju Titus Chacko
PURPOSE: Total neoadjuvant therapy (TNT) with pre-operative chemotherapy and chemoradiotherapy results in improved survival and is becoming the new standard of care in locally advanced rectal cancer (LARC). We describe our experience with TNT consisting of induction chemotherapy followed by chemoradiotherapy using full dose 5FU without oxaliplatin. METHODS: Adults with biopsy-proven, newly diagnosed LARC with high-risk characteristics on pelvic MRI (T4a or T4b, extramural vascular invasion, N2, mesorectal fascia involvement, enlargement/tumor deposits on lateral lymph nodes) were included...
July 21, 2023: Journal of Gastrointestinal Cancer
Marianne Linley L Sy-Janairo, Jose Isagani B Janairo
PURPOSE: Gastric cancer is an important health burden characterized by high prevalence and mortality rate. Upper gastrointestinal endoscopy coupled with biopsy is the primary means in which gastric cancer is diagnosed, and most of machine learning (ML) tools are developed in this area. This systematic review focuses on the applications of ML in gastric cancer that do not involve endoscopic image recognition. METHODS: A systematic review of ML applications that do not involve endoscopy and are relevant to gastric cancer was performed in two databases and independently evaluated by the two authors...
July 21, 2023: Journal of Gastrointestinal Cancer
Fatah Tidadini, Bertrand Trilling, Jean-Louis Quesada, Julio Abba, Alison Foote, Jean-Luc Faucheron, Catherine Arvieux
PURPOSE: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new surgical technique, developed for the treatment of peritoneal carcinomatosis (PC). In this retrospective observational study we assessed the impact of body mass index (BMI) on postoperative pain and opioid consumption. METHODS: We analyzed pain scores after 100 PIPAC procedures using either oxaliplatin or doxorubicin-cisplatin performed in 49 patients with PC between July 2016 and September 2020...
July 17, 2023: Journal of Gastrointestinal Cancer
Joel M Baumgartner, Gregory P Botta
PURPOSE: This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. METHODS: We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications...
July 12, 2023: Journal of Gastrointestinal Cancer
Feng Chen, Wang Zhang, Xinran Gao, Hui Yuan, Kehai Liu
BACKGROUND: Hepatocellular carcinoma (HCC), a primary liver cancer with high mortality, is the most common malignant tumor in the world. Currently, the effect of routine treatment is poor, especially for this kind of cancer with strong heterogeneity and late detection. In the past decades, the researches of gene therapy for HCC based on small interfering RNA have blossomed everywhere. This is a promising therapeutic strategy, but the application of siRNA is limited by the discovery of effective molecular targets and the delivery system targeting HCC...
July 11, 2023: Journal of Gastrointestinal Cancer
Kimia Mohammadnezhad, Mahmod Reza Sahebi, Sudabeh Alatab, Alireza Sadjadi
PURPOSE: Gastric cancer (GC) ranks as the 7th most common cancer worldwide and a leading cause of cancer mortality. In Iran, stomach malignancies are the most common fatal cancers with higher than world average incidence. In recent years, methods like machine learning that provide the opportunity of merging health issues with computational power and learning capacity have caught considerable attention for prediction and diagnosis of diseases. In this study, we aimed to model GC data to find risk factors and identify GC cases in Golestan Cohort Study (GCS), using gradient boosting as a machine learning technique...
July 10, 2023: Journal of Gastrointestinal Cancer
Udhayvir Singh Grewal, Manik Aggarwal, Shiva Jashwanth Gaddam, Prabhat Kumar, Subhash Chandra Garikipati, Naomi Fei
INTRODUCTION: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States (US), however racial disparities in outcomes persist. We sought to assess the correlation of availability of primary care physicians (PCPs) and racial disparities in CRC-related mortality. METHODS: We studied the correlation between age-adjusted incidence and mortality rates of CRC among all 50 states and the District of Columbia (D.C.) from the Center for Disease Control (CDC) Wide-Ranging Online Data for Epidemiologic Research (WONDER) with the number of actively practicing PCPs in all 50 states and D...
July 7, 2023: Journal of Gastrointestinal Cancer
Beliz Bahar Karaoglan, Cihangir Akyol, Ali Ekrem Unal, Ayhan Kuzu, Berna Savaş, Güngör Utkan
PURPOSE: Colorectal cancer (CRC) is the second most common cancer in both women and men. Microsatellite instability-high (MSI-H) CRC is a molecular subgroup and has distinct clinical and pathologic features from microsatellite stable (MSS) CRC. Studies have suggested an association between hereditary antigens in ABO blood group system and the risk of developing various cancers but the relationship between blood groups and MSI-H CRC has not been investigated. This study aimed to investigate this relationship and its possible effect on clinicopathological features in patients with CRC...
July 7, 2023: Journal of Gastrointestinal Cancer
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.